Skip to main content

Die Poliomyelitisschutzimpfung

  • Chapter
Handbuch der Schutzimpfungen

Zusammenfassung

Die Entwicklung wirksamer und zuverlässiger Impfverfahren ist von einer Reihe von Voraussetzungen abhängig, die in Hinsicht auf die Poliomyelitis erst in jüngster Vergangenheit erfüllt werden konnten.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Anders, W.: 1. Lagebericht des Bundesgesundheitsamts. „Über die Kinderlähmung”. 1963.

    Google Scholar 

  • Anders, W.: Die Poliomyelitis-Situation in der Bundesrepublik und in Europa. Ärztl. Mitt. S. 1691. (1962).

    Google Scholar 

  • Anderson: zit. n. Wiesmann u. Wegmann (1962).

    Google Scholar 

  • Armstrong, C.: The experimental transmission of poliomyelitis to the Eastern cotton rat, Sigmodon hispidus hispidus. Publ. Hlth Rep. 54, 1719 (1939 a).

    Article  Google Scholar 

  • Armstrong, C.: Successful transfer of the Lansing strain of poliomyelitis virus from the cotton rat to the white mouse. Publ. Health Eep. 54, 2302 (1939b).

    Google Scholar 

  • Barnett, E., and S. Baron: Antibody Response to Increased Amounts of Poliomyelitis vaccine. Amer. J. Hyg. 71 59 (1960).

    PubMed  CAS  Google Scholar 

  • Batson, R., A. Christie and W. Cheatham: The infant’s serologic response to live poliomyelitis virus vaccine. J. Amer. med. Ass. 180, (1962).

    Google Scholar 

  • Bauer, H., R. Barr, H. Kleinman, A. Kimball, M. Cooney, J. Bearman and W. Mathey: Minnesota studies with oral poliomyelitis vaccines. Second Internat. Conference on Live Poliovirus Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 357. Washington D. C., 1960.

    Google Scholar 

  • Baumann, Th., u. Felder: Begleiterscheinungen und Komplikationen bei der Vaccination gegen Poliomyelitis. Schweiz. med. Wschr. 87, 964 (1957).

    PubMed  CAS  Google Scholar 

  • Belian, W.: Virologische und serologische Auswertung der Schutzimpfung in der DDR im Jahre 1960 mit der Lebend-Polio-Vakzine nach Sabin-Tschumakow. Zbl. Bakt., I. Abt. Orig. 184, 150 (1962).

    Google Scholar 

  • Bhatt, P., M. Brooks and J. Fox: Extent of infection with poliomyelitis virus in household associated of clinical cases as determinded serologically and by virus isolation using tissue culture methods. Amer. J. Hyg. 61, 287 (1955).

    PubMed  CAS  Google Scholar 

  • Bodian, D.: Experimental studies of passive immunization against poliomyelitis. II. The prophylactic effect of human gammaglobulin on paralytic poliomyelitis in cynomolgus monkeys after virus feeding. Amer. J. Hyg. 56, 78 (1952).

    PubMed  CAS  Google Scholar 

  • Bodian, D.: III. Passive-active immunization and pathogenesis after virus feeding in chimpanzees. Amer. J. Hyg. 58, 81 (1953).

    PubMed  CAS  Google Scholar 

  • Bodian, D.: Viremia in experimental poliomyelitis. II. Viremia and the mechanism of the “provocing” effect of injections or trauma. Amer. J. Hyg. 60, 358 (1954).

    PubMed  CAS  Google Scholar 

  • Bodian, D.: Viremia, invasiveness and the influence of injections. Ann. N. Y. Acad. Sci. 61, 877 (1955).

    Article  PubMed  CAS  Google Scholar 

  • Bodian, D. and H. Howe: Non paralytic poliomyelitis in the Chimpanzee. J. exp. Med. 81, 255 (1945).

    Article  PubMed  CAS  Google Scholar 

  • Bodian, D. and H. Howe and R. S. Paffenberger: Poliomyelitis infections in households. Frequency of viremia and specific antibody response. Amer. J. Hyg. 60, 83 (1954).

    PubMed  CAS  Google Scholar 

  • Bodian, D. and H. Howe and R. S. Paffenberger, and N. Nathanson: Inhibitory effects of passive antibody on virulent poliovirus excretion and on immune response in Chimpanzees. Bull. Johns Hopk. Hosp. 107, 143 (1960).

    CAS  Google Scholar 

  • Brodie, M., u. W. H. Park: (Zit. n. Vivell) J. Amer. med. Ass. 105, 1089 (1935).

    Article  Google Scholar 

  • Brownlee, K. A.: Statistics of the 1954 Poliovaccine Trials. J. Amer. Statist. Assoc. 50, 1005 (1955).

    Article  Google Scholar 

  • Bundesgesundheitsamt: Zweites Gutachten über den Stand der Schutzimpfung gegen die spinale Kinderlähmung. Abh. aus d. Bundesgesundheitsamt 3. Berlin-Göttingen-Heidelberg: Springer 1959.

    Google Scholar 

  • Burnet, F. M., and J. Macnamara: Immunological differences between strains of poliomyelitis virus. Brit. J. exp. Path. 12, 57 (1931).

    Google Scholar 

  • Charney, J., A. A. Tytell, R. A. Machlowitz and M. R. Hilleman: Development of an Purified Poliomyelitis Virus Vaccine. J. Amer. med. Ass. 177, 591 (1961).

    Article  CAS  Google Scholar 

  • Christensen, Ch. N.: Reactions to poliomyelitis vaccine. J. Amer. med. Ass. 171, 869 (1959).

    Article  CAS  Google Scholar 

  • Chumakov, M. P.: On Mass oral Immunization of Population in the Soviet Union against Poliomyelitis with Live Vaccine from A. B. Sabin’s Attenuated Strains. Report No. 2 Academy of Medical Sciences of the USSR, Institute for Poliomyelitis Research. Moscow 1960.

    Google Scholar 

  • Chumakov, M. P.: Some results of the work on mass immunization of the population in the Soviet Union with live poliovirus Vaccine from Albert B. Sabin’s strains. The control of poliomyelitis by live poliomyelitis vaccine. Edited by J. Weissfeiler. Budapest 1961.

    Google Scholar 

  • Commitee on Typing of the National Foundation for Infantile Paralysis: Immunologic classification of poliomyelitis viruses: Discussion of results and general summary. Amer. J. Hyg. 54, 191 (1951).

    Google Scholar 

  • Dane, D., G. Dick, J. Comolly, O. Fisher and F. McKeown: Vaccination against poliomyelitis with live virus vaccines. Brit. med. J. 1957 I, 59.

    Article  Google Scholar 

  • Dane, D., G. Dick, J. Comolly, O. Fisher and F. McKeown, M. Briggs, R. Nelson, J. McAlister, J. Conolly, M. Haire, F. McKeown and D. Field: Vaccination against poliomyelitis with the live virus vaccines. VI Changes in Sabin type II oral vaccine virus after human passage. Brit. med. J. 1961a II 259.

    Article  Google Scholar 

  • Dane, D., G. Dick, M. Briggs, R. Nelson, J. McAllister, J. Conolly, M. Haire, F. McKeown and C. Field: Vaccination against poliomyelitis with live virus vaccines. VIII. Changes in Sabin type I oral vaccine virus after multiplication in the intestinal tract. Brit. med. J. 1961 b/II, 269.

    Article  Google Scholar 

  • Dane, D. S., C. W. A. Dick, J. J. McAlister and R. T. Nelson: Epidemic control of poliomyelitis with inactive virus vaccines. Studies in cynomolgus monkeys. Lancet 1960 I, 845.

    Article  Google Scholar 

  • Dick, G., D. Dane, J. McAlister, M. Briggs, R. Nelson and C. Field: Vaccinations against poliomyelitis with live virus vaccines. VII. Effect of previous Salk vaccination on virus-excretion. Brit. med. J. 1961 II, 266.

    Article  Google Scholar 

  • Dulbecco, R., and M. Vogt: Plaque formation and isolation of pure lines with poliomyelitis viruses. J. exp. Med. 99, 167 (1954).

    Article  PubMed  CAS  Google Scholar 

  • Ehrengut, W., u. H. Rüstow: Zusammenhänge zwischen Pockenschutzimpfung und Poliomyelitis. Öff. Gesundh.-Dienst 19, 64 (1957).

    CAS  Google Scholar 

  • Enders, J., T. Weller and F. Robbins: Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 109, 85 (1949).

    Article  PubMed  CAS  Google Scholar 

  • Enders, J., T. Weller and F. Robbins: Alteration in pathogenicity for monkeys of Brunhilde strain of poliomyelitis following cultivation in human tissues. Fed. Proc. 11, 467 (1952).

    Google Scholar 

  • Flexner, S., and P. A. Lewis: The nature of the virus of epidemic poliomyelitis. J. Amer. med. Ass. 53, 2095 (1909).

    Article  Google Scholar 

  • Flexner, S., and P. A. Lewis: Experimental poliomyelitis in monkeys. Seventh note: Active immunization and passive serum protection. J. Amer. med. Ass. 54, 1780 (1910).

    Article  Google Scholar 

  • Fox, J., H. Gelfand, P. Bhatt, D. Le Blanc and D. Conwell: Immunizing infections with poliomyelitis viruses and seroimmune patterns in Southern Louisiana. Ann. N. Y. Acad. Sci. 61, 968 (1955).

    Article  PubMed  CAS  Google Scholar 

  • Fox, J., H. Gelfand, P. Bhatt, D. Le Blanc and D. Conwell D. Le Blanc, H. M. Gelfand, D. J. Clemmer and L. Potash: Spread of a vaccine strain of poliomyelitis in Southern Louisiana communities. Second Internat. Conference on Live Poliovirus Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 144. Washington D. C., (1960).

    Google Scholar 

  • Francis-Bericht: Evaluation of 1954 Field Trial of Poliomyelitis vaccine. Summary Report. Vaccine Evaluation Center University of Michigan. Ann Arbor, Michigan April 12, 1955.

    Google Scholar 

  • Francis jr., T.: Evaluation of the 1954 poliomyelitis vaccine field Trial. Further studies of results determining the effectiveness of poliomyelitis vaccine (Salk), in proventing paralytic poliomyelitis. J. Amer. med. Ass. 158, 1266 (1955).

    Article  Google Scholar 

  • Francis jr., T. R. F. Korns, R. B. Voight, M. Boisen, F. M. Hephill, J. A. Napier and E. Tolchinsky: An evaluation of the 1954 poliomyelitis vaccine Trials. Summary report. Amer. J. publ. Hlth, Part 2, 45, 1 (1955).

    Google Scholar 

  • Gaisford, W., G. Feldman and F. Perkins: The response of infants to poliomyelitis immunization after neonatal immunization with tripleantigen. J. Pediat. 58, 493 (1961).

    Article  PubMed  CAS  Google Scholar 

  • Gard, S.: The virus of Poliomyelitis. In: D. Hallauer u. K. F. Meyer: Handbuch der Virusforschung, 4. Band, S. 581. Wien: Springer 1958.

    Google Scholar 

  • Gard, S.: Field and laboratory experiences with the CHAT strain type I poliovirus. Second Internat. Conference on Live Poliovirus Vaccines. Pan American Internat. Bureau. Washington D. C.: Scientific Publication 50, 187 (1960).

    Google Scholar 

  • Gelfand, H. M., A. H. Holguin and R. A. Feldman: Community-wide type 3 oral poliovirus vaccinetion in Atlanta, Ga. (1961). J. Amer. med. Ass. 181, 281 (1962).

    Article  CAS  Google Scholar 

  • Graser, F., u. G. Fortong: Nervöse Komplikationen bei der Poliomyelitisschutzimpfung. Mschr. Kinderheilk. 107, 227 (1959).

    PubMed  CAS  Google Scholar 

  • Haas, R., u. W. Keller: Zur Problematik der Unschädlichkeitsprüfung von Poliomyelitisimpfstoffen und gegenwärtigen Stand ihrer praktischen Anwendung. Dtsch. med. Wschr. 82, 1042 (1957).

    Article  PubMed  CAS  Google Scholar 

  • Haas, R., u. R. Thomssen: Über den Entwicklungsstand der in der Immunbiologie gebräuchlichen Adjuvantien. Ergebn. Mikrobiol. 34, 27 (1961).

    CAS  Google Scholar 

  • Haas, R., u. R. Thomssen V. Dostal, J. Lindemann, G. Maas u. R. Thomssen: Virologische Untersuchungen nach oraler Poliomyelitis-Schutzimpfung (Sabin). I. Untersuchungen über Virusausscheidung, Antikörperbildung und die Häufigkeit von Kontaktinfektionen. Dtsch. med. Wschr. 86, 2413 (1961).

    Article  PubMed  CAS  Google Scholar 

  • Hale, J. H., M. Doraisingham, L. H. Lee, K. Koragaratnam, K. W. Leong and E. S. Monteiro: Large-scale use of Sabin Type 2 attenuated poliovirus vaccine in Singapore during a Type 1 poliomyelitis epidemic. First Internat. Conference on Live Poliovirus Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 44, 286. Washington D. C., 1959.

    Google Scholar 

  • Hale, J., L. Lee and P. Gardner: Interference patterns encountered when using attenuated poliovirus vaccines. Brit. med. J. 1961 II 728.

    Article  Google Scholar 

  • Hammon, W., L. L. Coriell, P. F. Wehrle and J. Stokes: Evaluation of red cross gamma globulin as a prophylactic agent for poliomyelitis. 4. Final report of results based on clinical diagnosis. J. Amer. med. Ass. 151, 1272 (1953).

    CAS  Google Scholar 

  • Hammon, W., L. L. Coriell, P. F. Wehrle and J. Stokes, E. H. Ludwig, R. M. McAllister, A. E. Greene, G. E. Sather and P. F. Wehrle: Evaluation of red cross gamma globulin as a prophylactic agent for poliomyelitis. 5. Reanalysis of results based on laboratory confirmed cases. J. Amer. med. Ass. 156, 21 (1954).

    Article  CAS  Google Scholar 

  • Hein, E.: Erfahrungen über die Polioschluckimpfung in Bayern und weitere Ausblicke. Bayer. Ärztebl. 17, 538 (1962).

    Google Scholar 

  • Henneberg, G.: Poliomyelitis-Schutzimpfung mit Lebendimpfstoff (Cox) in Berlin im Mai 1960. Bundesgesundheitsblatt 1962, 153.

    Google Scholar 

  • Hilber, H.: Differentialdiagnostische Erwägungen bei Begleiterscheinungen der Polioschluckimpfung. Bayer. Ärztebl. 17, 448 (1962).

    Google Scholar 

  • Holt, L. B.: A re-assessment of the risk of provoking paralytic poliomyelitis by making prophylactic inoculations against diphtheria and pertussis. J. Hyg. 57, 150 (1959).

    Article  CAS  Google Scholar 

  • Horstmann, D., and R. McCollum: Poliomyelitis virus in human blood during the “minor illness” and the asymptomatic infection. Proc. Soc. exp. Biol. (N. Y.) 82, 434 (1953).

    Google Scholar 

  • Horstmann, D., and R. McCollum and A. Maseola: Viremia in human poliomyelitis. J. exp. Med. 99, 355 (1954).

    Google Scholar 

  • Howe, H.: Poliomyelitis Infection in Immunized Chimpanzees. Ann. N. Y. Acad. Sci. 61, 1014 (1955).

    Article  PubMed  CAS  Google Scholar 

  • Howe, H.: The quantitation of poliomyelitis virus in the human alimentary tract with reference to co-existency levels of homologous serum neutralizing antibody. Amer. J. Hyg. 75, 1 (1962).

    PubMed  CAS  Google Scholar 

  • Joppich, G.: Die orale Poliomyelitisimpfung in der Bundesrepublik. Ärztl. Mitt. (Köln) 3, 139 (1963).

    Google Scholar 

  • Kanda, Y., and J. Melnick: In vitro differentiation of virulent and attenuated polioviruses by their growth characteristics on MS cells. J. exp. Med. 109 9 (1959).

    Article  PubMed  CAS  Google Scholar 

  • Kleinman, H., R. N. Barr, H. Bauer, A. C. Kimball, M. K. Cooney, J. E. Bearman and W. E. Mathey: A Comparison of Monovalent and Trivalent Vaccines. Second International Conference on Live Poliomyelitis Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 341. Washington D. C, 1960.

    Google Scholar 

  • Kleinschmidt, H.: Die Beurteilung von Impfschäden —Meldungen nach Impfung gegen Kinderlähmung. Paediat. int. (Roma) 9, 635 (1959).

    Google Scholar 

  • Kochs, H.: Zur oralen Schutzimpfung gegen Poliomyelitis in West-Berlin 1960. Bundesgesundheitsblatt 1961 149.

    Google Scholar 

  • Kolmer, J. A., G. F. Klugh u. J. Rule: Zit. n. Vivell. J. Amer. med. Ass. 104 456 (1935).

    Article  Google Scholar 

  • Koprowski, H., G. Hervis and Th. Norton: Immune responses in human volonteers upon administration of a rodent adapted strain of poliomyelitis virus. Amer. J. Hyg. 55, 108 (1952).

    PubMed  CAS  Google Scholar 

  • Koprowski, H., G. Hervis and Th. Norton: Historical aspects of the development of live virus vaccines in poliomyelitis. Amer. J. Dis. Child. 100 428 (1960).

    CAS  Google Scholar 

  • Koprowski, H., G. Hervis and Th. Norton and D. Nelson: Further studies on oral administration of living poliomyelitis virus to human subjects. Proc. Soc. exp. Biol. (N. Y.) 82, 277 (1953).

    CAS  Google Scholar 

  • Krugman, S., J. Warren, M. S. Eiger, P. H. Herman, R. M. Michaels and A. B. Sabin: Immunization with live attenuated polio virus vaccine. Amer. J. Dis. Child. 101 23 (1961).

    PubMed  CAS  Google Scholar 

  • Landsteiner, K.: Erster Bericht über die Übertragbarkeit der Poliomyelitis in der Sitzung der Gesellschaft der Ärzte in Wien am 18. Dezember 1908. Wien. klin. Wschr. 21, 1830 (1908).

    Google Scholar 

  • Langmuir, A. D., N. Nathanson and W.J. Hall: Surveillance of poliomyelitis in the United States in 1955. Amer. J. publ. Hlth 46, 75 (1956).

    Article  CAS  Google Scholar 

  • Langmuir, A. D., N. Nathanson and W.J. Hall: „Inaktivierte Virusvakzine“; Schutzwirkung”. 5. Internat. Poliomyelitiskonferenz, Kopenhagen 1960. Excerpta Medica. Internat. Congress Series No. 27. Alete-Reihe 2, Berichterstattung von Schweier und Vivell, S. 29 (1960). Herausgeber: „Alete“ Pharmaz. Produkte G. m. b. H. München.

    Google Scholar 

  • Langmuir, A. D.: Epidemiologic Considerations. J. Amer. med. Ass. 175, 840 (1961).

    Article  CAS  Google Scholar 

  • Lennartz, H., u. L. Valenciano: Virologische Untersuchungen zur oralen Schutzimpfung gegen Poliomyelitis in Westberlin 1960. Dtsch. med. Wschr. 86, 1497 (1961).

    Article  PubMed  CAS  Google Scholar 

  • Lepow, M. L., R. J. Warren, V. G. Ingram, S. C. Dangherty and F. C. Robbins: Sabin type I (L Sc 2 a b) oral poliomyelitis vaccine. Effect of dose upon response of newborn infants. Amer. J. Dis. Child. 104, 67 (1962).

    PubMed  CAS  Google Scholar 

  • Levine, S., N. Goldblum and C. Friedman: Virologie findings and antibody response of newborn fed multiple type oral poliomyelitis vaccine. Amer. J. Hyg. 74, 59 (1961).

    Google Scholar 

  • Li, C., and K. Habel: Adaptation of Leon strain of poliomyelitis to mice. Proc. Soc. exp. Biol. (N. Y.) 78, 233 (1951).

    CAS  Google Scholar 

  • Li, C., and K. Habel, and M. Schaeffer: Adaptation of type I poliomyelitis virus to mice. Proc. Soc. exper. Biol. (N. Y.) 82, 477 (1953).

    CAS  Google Scholar 

  • Li, C., and K. Habel, and M. Schaeffer: Isolation of non-neurotropic variants of type I poliomyelitis virus. Proc. Soc. exper. Biol. (N. Y.) 87, 148 (1954).

    CAS  Google Scholar 

  • Li, C., and K. Habel, and M. Schaeffer and D. Nelson: Experimentally produced variants of poliomyelitis virus combining in vivo and in vitro techniques. Ann. N. Y. Acad. Sci. 61, 902 (1955).

    Article  PubMed  CAS  Google Scholar 

  • Liebe, S., u. W. Wöckel: Landrysche Paralyse nach Poliomyelitisschutzimpfung. Dtsch. med. Wschr. 84, 909 (1959).

    Article  PubMed  CAS  Google Scholar 

  • Lwoff, A.: Factors influencing the evolution on viral diseases at the cellular level and in the organism. Bact. Rev. 23, 100 (1959).

    Google Scholar 

  • Maròczi, I.: Vaccinia-Antihämagglutinintiter des Serums der nach einer mit lebender, geschwächter Poliovirusvakzine ausgeführten Impfung mit Pockenlymphe geimpften Säuglinge. Orv. Hetil. 3, 104 (1963).

    Google Scholar 

  • McBride, W. D.: Antigenic analysis of polioviruses by kinetic studies of serum neutralization. Virology 7, 45 (1959).

    Article  PubMed  CAS  Google Scholar 

  • Melnick, J. L., M. Benyesh-Melnick and J. C. Brennan: Studies on live poliovirus vaccine. Its neurotropic activity in monkeys and its increased neurovirulence after multiplication in vaccinated Children. J. Amer. med. Ass. 171, 1165 (1959).

    Article  Google Scholar 

  • Melnick, J. L., M. Benyesh-Melnick and J. C. Brennan: Problems associated with the live poliovirus vaccine and its progeny after multiplication in man. Second Internat. Conference on Live Polio Virus Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 12. Washington D. C., 1960.

    Google Scholar 

  • tMelnick, J. L., M. Benyesh-Melnick and J. C. Brennan, R. Penna and M. Yow: Effectiveness of Salk-Vaccine. J. Amer. med. Ass. 175, 1159 (1961).

    Article  Google Scholar 

  • Miller, H. G., and J. B. Stanton: Neurological sequelae of prophylactic inoculation. Quart. J. Med., New Series XXIII, 89(1954).

    Google Scholar 

  • Müller, H.: Die Kinderlähmung in Altbayern. Münch. med. Wschr. 1938, 353.

    Google Scholar 

  • Munk, K.: Über die Immunität gegen Poliomyelitis. Untersuchungen mit dem Neutralisationstest. Münch. med. Wschr. 99, 1781 (1957).

    PubMed  CAS  Google Scholar 

  • Murray, R.: Inaktivierte Vakzine-Schutzimpfung. Standardisierung der Aktivität. 5. Internat. Poliomyelitiskonferenz, Kopenhagen 1960. Excerpta Medica. Internat. Congress Series No. 27. Alete-Reihe 2, Berichterstattung von Schweier und Vivell, S. 38 (1960) Herausg.: Alete Pharm. Produkte GmbH. München.

    Google Scholar 

  • Nathanson, N., L. D. Thrupp, W. M. J. Hall, A. D. Langmuir, R. G. Cornell, H. E. Forester, R. E. Churon, J. B. Hall, M. Hildebrand, H. J. Shanghnessy and R. Morrissey: Epidemic poliomyelitis during 1956 in Chicago and Cook Country, Illinois. Amer. J. Hyg. 70, 107 (1959).

    Google Scholar 

  • Niederman, J. C., D. M. Horstmann and E. M. Opton: A survey of poliomyelitis antibody levels in New Haven, Connecticut, 1957–1958. Amer. J. Hyg. 72, 218 (1960).

    PubMed  CAS  Google Scholar 

  • Paul, J. R.: Status of vaccination against poliomyelitis with particular reference to oral vaccination. New Engl. J. Med. 264, 651 (1961).

    Article  Google Scholar 

  • Pfaundler, M.: Über stille Feiung (erläutert am Beispiel der Heine-Medinschen Krankheit). Münch, med. Wschr. 75, 45 (1928).

    Google Scholar 

  • Prem, K., and J. McKelvey: Immunologic response of pregnant women to oral trivalent poliomyelitis vaccine. First International Conference on Live Poliovirus Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 44, 260. Washington D. C., 1959.

    Google Scholar 

  • Prem, K., and J. McKelvey: J. W. Fergus, J. E. Mathers and L. McKelvey: Vaccination of pregnant women and young infants with trivalent oral attenuated live poliomyelitis vaccine. Second internat. conference on live polio-virus vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 207. Washington D. C., 1960.

    Google Scholar 

  • Prigge, R., O. Günther, O. Bonin, G. Eissner unter Mitwirkung von J. Hallervorden u. J. W. Spaar: Probleme der staatlichen Prüfung von Poliomyelitis-Impfstoffen. Dtsch. med. Wschr. 81, 325, 377 (1956).

    Article  PubMed  CAS  Google Scholar 

  • Raettig, H.: Die Provokation einer Infektionskrankheit durch Schutzimpfung. Bundesgesundheitsbl. 9, 129 (1958).

    Google Scholar 

  • Raettig, H.: Die epidemiologischen Auswirkungen der Poliomyelitis-Impfung in West-Berlin. Zbl. Bakt., I. Abt. Orig. 184, 142 (1962).

    CAS  Google Scholar 

  • Ramon, G.: Vaccination contre la poliomyélite et vaccination antidiphthérique. Resultats respectifs. Etude comporative. Conclusion. Rev. Immunol. (Paris) 27, 469 (1960).

    Google Scholar 

  • Ramos Alvarez, M., M. Bustamente and R. Alvarez Alba: Use of Sabin’s live poliovirus vaccine in Mexico. Results of a large-scale trial. Second Internat. Conference on Live Poliovirus Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 386. Washington D. C., 1960.

    Google Scholar 

  • Ratner, H., H. R. Cox, B. G. Greenberg, H. Kleinman and P. Meier: (Panel-Discussion) The Present Status of Polio Vaccines. Illinois med. J. 2, 118 (1960).

    Google Scholar 

  • Revenok, N. D.: Observations over children inoculated with live poliovirus vaccine during the incubation period of measles. Zit. n. Zbl. Kinderheilk. 83, 272 Pediatriya (Moskau) 40 54 (1961).

    Google Scholar 

  • Rivers, T. M.: Zit. n. Vivell (1958). J. publ. Hlth 26, 136 (1936).

    Article  CAS  Google Scholar 

  • Roca-Garcia, M., A. Moyer and H. Cox: Poliomyelitis. I. Propagation of the MEF 1 strain of poliomyelitis virus in the sockling hamster. Proc. Soc. exp. Med. (N. Y.) 81, 513 (1952a).

    Google Scholar 

  • Roca-Garcia, M., A. Moyer and H. Cox: Poliomyelitis. II. Propagation of MEF 1 strain of poliomyelitis virus in developing chick embryo by Yolk sac inoculation. Proc. Soc. exp. Med. (N. Y.) 81, 519 (1952b).

    CAS  Google Scholar 

  • Römer, P. H.: Weitere Mitteilungen über experimentelle Affenpoliomyelitis. Münch. med. Wschr. 57, 229 (1910).

    Google Scholar 

  • Sabin, A.: Characteristics and genetic potentialities of experimentally produced and naturally occuring variants of poliomyelitis virus. Ann. N. Y. Acad. Sci. 61, 924 (1955a).

    Article  PubMed  CAS  Google Scholar 

  • Sabin, A.: Immunization of chimpanzees and human beings with avirulent strains of poliomyelitis virus. Ann. N. Y. Acad. Sci. 61, 1050 (1955b).

    Article  PubMed  CAS  Google Scholar 

  • Sabin, A.: Present status of attenuated live-virus poliomyelitis vaccine. J. Amer. med. Ass. 162, 1589 (1956).

    Article  CAS  Google Scholar 

  • Sabin, A.: Present position of immunization against poliomyelitis with live virus vaccine. Brit. med. J. 1959, 5123.

    Google Scholar 

  • Sabin, A.: Live, orally given poliovirus vaccine effects of rapid mass immunization on population under conditions of massive enteric infektion with other viruses. J. Amer. med. Ass. 173, 1521 (1960).

    Article  CAS  Google Scholar 

  • Sabin, A.: Eradication of poliomyelitis. Ann. intern. Med. 55, 353 (1961).

    PubMed  CAS  Google Scholar 

  • Sabin, A., and Olitzky 1936: Zit. n. Holt and McIntosh Pediatrics, 12th Edition, S. 1257 New York 1953.

    Google Scholar 

  • Sabin, A., and Olitzky, M. Ramos Alvarez, J. Alvarez Amezquita, W. Pelon, R. Michaelis, S. Spigland, M. Koch, J. Barnes and J. Rhim: Effects of rapid mass immunization of a population with live oral poliovirus vaccine under conditions of massive enteric infection with other viruses. Second internat. conference on live poliovirus vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 377. Washington D. C., 1960.

    Google Scholar 

  • Sabin, A., and Olitzky, M. Ramos Alvarez, J. Alvarez Amezquita, W. Pelon, R. Michaelis, S. Spigland, M. Koch, J. Barnes and J. Rhim R. Michaels, J. Spigland, W. Pelon, S. Rhim and R. Wehr: Community-wide use of oral poliovirus vaccine. Amer. J. Dis. Child. 101, 546 (1961).

    PubMed  CAS  Google Scholar 

  • Salk, J. E. unter Mitarbeit von B. L. Bennett, L. J. Lewis, E. N. Ward and J. S. Jounger: Studies in human subjects on active immunization against poliomyelitis. J. Amer. med. Ass. 151, 1081 (19

    CAS  Google Scholar 

  • Salk, J. E. unter Mitarbeit von B. L. Bennett, L. J. Lewis, E. N. Ward and J. S. Jounger, P. L. Bazeley, B. L. Bennett, U. Krech, E. Ward and J. S. Youngner: Studies in Human Subjects on Active Immunization against Poliomyelitis. Am. J. publ. Hlth 44, 994 (1954).

    CAS  Google Scholar 

  • Salk, J. E. unter Mitarbeit von B. L. Bennett, L. J. Lewis, E. N. Ward and J. S. Jounger, P. L. Bazeley, B. L. Bennett, U. Krech, E. Ward and J. S. Youngner, P. L. Bazeley, B. L. Bennett, U. Krech, E. Ward and J. S. Youngner: A concept of the mechanism of immunity for preventing paralysis in poliomyelitis. Ann. N. Y. Acad. Sci. 61, 1023, (1955).

    Article  PubMed  CAS  Google Scholar 

  • Salk, J. E. unter Mitarbeit von B. L. Bennett, L. J. Lewis, E. N. Ward and J. S. Jounger, P. L. Bazeley, B. L. Bennett, U. Krech, E. Ward and J. S. Youngner, P. L. Bazeley, B. L. Bennett, U. Krech, E. Ward and J. S. Youngner, P. L. Bazeley, B. L. Bennett, U. Krech, E. Ward and J. S. Youngner: Poliomyelitis vaccine in fall of 1955. Am. J. publ. Hlth 46, 1 (1956).

    Article  CAS  Google Scholar 

  • Salk, J. E. Persistence of immunity after administration of formalin-treated poliovirus vaccine. Lancet 1960 II, 175.

    Google Scholar 

  • Schär, M.: Stand der Schutzimpfungen mit Lebendvakzinen gegen die Poliomyelitis in der Schweiz. Bundesgesundheitsblatt 4, 220 (1960).

    Google Scholar 

  • Schär, M.: Über die Erfahrungen mit der Schluckimpfung gegen die Poliomyelitis in der Schweiz. Bayer. Ärztebl. 17, 14 (1962).

    Google Scholar 

  • Schaltenbrandt, G., H. Spuler u. H. C. Hopf: Neurologische Komplikationen nach Schutzimpfungen mit lebendem Poliomyelitisvirus nach Sabin. Münch. med. Wschr. 104, 1917 (1962).

    Google Scholar 

  • Scheele-Bericht: 21. S. Deptm. of Health, Educ. and Welfare. Publ. Health Service, Washington D. C., 10. 6. 1955.

    Google Scholar 

  • Seiffert, G.: Ergebnisse der oralen Impfung gegen Poliomyelitis in der DDR 1960 und Schlußfolgerungen daraus. Münch. med. Wschr. 103, 1268 (1961).

    Google Scholar 

  • Siegel, M., and M. Greenberg: Poliomyelitis in pregnancy: Effect on fetus and newborn infant. J. Pediat. 49, 280 (1956).

    Article  PubMed  Google Scholar 

  • Siegert, R., u. G. Enders-Ruckle: Zur Beurteilung zentralnervöser Impfschäden nach Poliomyelitis-Schutzimpfung mit inaktivierter Vakzine (Salk). Dtsch. med. Wschr. 86, 193 (1961).

    Article  Google Scholar 

  • Skovránek, K., and V. Záček: Oral poliovirus vaccine (Sabin) in Czeckoslovakia. J. Amer. med. Ass. 176, 524 (1961).

    Article  Google Scholar 

  • Smorodintsev, A., E. F. Davidenkova, A. J. Drobyshevskaya, T. E. Klyuchareva, V. J. Ilyenko, O. M. Chalkina, K. G. Vasiliev, E. V. Glyn-Skaya, V. J. Votiakov and E. V. Feldman: Material for the Study of the Harmless ness of the Live Poliomyelitis Vaccine prepared from Sabin Strains. First Internat. Conference on Live Poliomyelitis Vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 44, 324. Washington D. C., 1959.

    Google Scholar 

  • Smorodintsev, A. A.: Second internat. conference on live poliovirus vaccines. Discussion. Second internat. conference on live poliovirus vaccines. Pan American Sanitary Bureau. WHO. Scientific Publication No. 50, 49. Washington D. C., 1960.

    Google Scholar 

  • Smorodintsev, A. A.: Summary Report of the National Advisory Commitee für evaluation of Gammaglobulin. J. Amer. med. Ass. 154, 1086 (1954).

    Article  Google Scholar 

  • Truckenbrodt, H.: Über Gesundheitsstörungen nach Poliomyelitisschutzimpfung. Z. Kinderheilk. 86. 619 (1962).

    Article  PubMed  CAS  Google Scholar 

  • Uehlinger, E.: Landrysche Paralyse nach Poliomyelitis-Schutzimpfung. Schweiz. med. Wschr. 87, 813 (1957).

    PubMed  CAS  Google Scholar 

  • Vivell, O.: Die Poliomyelitisschutzimpfung. Schutzimpfungen. Herausgeg. von H. Spiess. Stuttgart: G. Thieme 1958.

    Google Scholar 

  • Vogt, M., R. Dulbecco and H. A. Wenner: Mutants of poliomyelitis viruses with reduced officiency of plating in grid medium and reduced neuropathogenicity. Virology 4, 141 (1957).

    Article  PubMed  CAS  Google Scholar 

  • Vogt, D., u. E. Schaudig: Erfahrungen mit einem Kombinationsimpfstoff gegen Poliomyelitis, Diphtherie und Tetanus. Münch. med. Wschr. 102, 1084 (1960).

    Google Scholar 

  • Wecker, E.: A simple test for serodifferentiation of poliovirus strains within the same type. Virology 10, 376 (1960).

    Article  PubMed  CAS  Google Scholar 

  • Weihl, C., D. Cornfeld, H. D. Riley, N. Huang and H. Cramblett: Purified Poliomyelitis Vaccine-Clinical Appraisal. J. Amer. med. Ass. 176. 409 (1961).

    Article  CAS  Google Scholar 

  • Weissfeiler, J.: The control of poliomyelitis by live poliovirus vaccine. Akademiai Kiadó, Budapest 1961.

    Google Scholar 

  • Wiesmann, E., u. T. Wegmann: Komplikationen nach peroraler Poliomyelitisschutzimpfung. Schweiz. med. Wschr. 92, 367 (1962).

    PubMed  CAS  Google Scholar 

  • Wilson, G. S., et al.: Poliomyelitis and tonsillectomie. Lancet 1955 II, 5.

    Google Scholar 

  • Wilson, G. S., et al.: Poliomyelitis and prophylactic inoculation against Diphtherie, Whooping-Cough, and Smallipox Report of the Medical Research Council Committee on inoculation procedures and neurological lesions. Lancet.1956 II, 1223.

    Google Scholar 

  • Windorfer, A.: Zur Frage der Poliomyelitis-Schutzimpfung während der Sommer-Herbst-Monate und während Epidemien. Dtsch. med. Wschr, 85. 1196 (1960).

    Article  CAS  Google Scholar 

  • Zimmerman, M. C.: Penicillinase — proved allergy to penicillin in poliomyelitis vaccine. J. Amer. med. Ass. 167, 1807 (1958).

    Article  CAS  Google Scholar 

  • Zischinsky, H., O. Pendl, Ch. Kunz u. K. Jellinger: Tödliche Encephalitis nach Poliomyelitis-Schutzimpfung. Klin. Wschr. 39, 638 (1961).

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

A. Herrlich

Rights and permissions

Reprints and permissions

Copyright information

© 1965 Springer-Verlag, Berlin/Heidelberg

About this chapter

Cite this chapter

Weber, G. (1965). Die Poliomyelitisschutzimpfung. In: Herrlich, A. (eds) Handbuch der Schutzimpfungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-92897-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-92897-0_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-92898-7

  • Online ISBN: 978-3-642-92897-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics